{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-006428","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2023-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.339578+00:00","generated_at":"2026-06-20T05:21:06.070424+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Silo Pharma announces board-authorized stock repurchase program up to $1M","bullets":["Board authorized repurchase of up to $1M of common stock in open market or privately negotiated transactions.","Company had approximately 3,138,797 shares outstanding as of November 10, 2022.","Repurchases subject to available liquidity, cash flows, market conditions, and regulatory limits.","Program does not obligate the company to repurchase any specific amount and may be suspended or discontinued any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-006428","json":"https://secwatch.observer/filing/0001213900-23-006428.json","markdown":"https://secwatch.observer/filing/0001213900-23-006428.md","text":"https://secwatch.observer/filing/0001213900-23-006428.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023006428/0001213900-23-006428-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023006428/ea172375-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T05:21:06.070424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}